IMMY

Antimicrobial Resistance & Infectious Diseases: A Growing Global Threat Antimicrobial resistance and infectious diseases continue to pose significant challenges to global health. The latest AMR & Infectious Diseases special issue of The Guardian compiles expert insights on these pressing issues, highlighting the critical need for innovative solutions. This edition features an interview with Dr. Tom Chiller from the CDC, where he discusses the life-saving impact of rapid fungal diagnostics in improving patient outcomes and combating antifungal resistance. 📖 Read the full issue and explore these vital perspectives: https://hubs.ly/Q02ZzjDg0 #WorldAMRWeek #AntifungalResistance #DiagnosticsMatter #GlobalHealth #OneHealth

🌍 IMMY at ICID 2024! We’re looking ahead to next week for the 20th International Congress on Infectious Diseases (ICID) in Cape Town, South Africa, from December 3-6! Join us at this premier global meeting, bringing together over 2,500 experts from 100+ countries to exchange insights, foster collaboration, and explore solutions for managing and preventing infectious diseases within a One Health context. IMMY’s Shadrack Were. will be on-site to connect with attendees and showcase our robust portfolio of rapid, accurate, and accessible fungal diagnostics—key tools that empower clinicians to provide faster, life-saving treatments. Let’s work together to transform infectious disease care. See you in Cape Town! #ICID2024 #InfectiousDiseases #FungalDiagnostics #OneHealth #DiagnosticsInnovation #ThinkFungus #TestFungus

🚨 Happening TODAY at 11AM CT! 🚨 Join the Public Health Innovation Lab (PHiL) for The Silent Epidemic: The Need for a Stronger IFI Response. 🌍 Invasive fungal infections (IFI) are a global health crisis affecting millions, yet they remain underrecognized and underfunded. This webinar will dive into: 🔎 The impact of IFIs worldwide 📉 Gaps in the current response 💡 Strategies for stronger global & local efforts 💬 Hear from an expert panel: Dr. Tom Chiller (CDC) Dr. Eric Goosby (UCSF) Oddi Aasheim (GAFFI) 📅 Free registration is still open! Join the conversation to raise awareness and drive change. 🔗 Register now and join us at 11AM: https://hubs.ly/Q02ZkBH80 (Details will also be shared live, so don’t miss out!) #SilentEpidemic #IFIResponse #FungalInfections #PublicHealth

Rapid fungal diagnostics don’t just save lives — they’re a critical tool in the fight against antifungal resistance. When patients get the right therapy faster, outcomes improve, hospital stays decrease, and inappropriate antimicrobial use is reduced. Delays in diagnosis can lead to higher mortality rates and contribute to bacterial resistance when antifungal infections are misdiagnosed. Learn more about the life-saving impact of rapid diagnostics in this insightful article by Dr. Tom Chiller MD MPHTM from the Centers for Disease Control and Prevention. Why antifungal resistance is a global health concern — and how we can fight it. 📖 Read here: https://hubs.ly/Q02Z9ZYZ0 #WorldAMRWeek #AntifungalResistance #OneHealth #DiagnosticsMatter #CDC #IMMY #GlobalHealth #FungalDignostics

#ThinkFungus #TestFungus

🌍 Recognizing World Antimicrobial Resistance (AMR) Awareness Week 🌍 Antimicrobial Resistance (AMR) is a growing global challenge that affects all of us. Among the lesser-discussed aspects of AMR is antifungal resistance, a serious concern that threatens the effectiveness of the limited antifungal treatments available today. At IMMY, we believe that rapid, reliable, and affordable diagnostics are critical tools in addressing AMR. Accurate diagnostics connect patients to the right treatment sooner, supporting antifungal and antibiotic stewardship while preserving the effectiveness of life-saving medications for future generations. Why Antifungal Resistance Matters: 1️⃣ Limited Treatment Options: Only a few classes of antifungal drugs exist. Resistance narrows these options, leaving vulnerable patients at greater risk. 2️⃣ Increased Mortality: Drug-resistant fungal infections are often life-threatening, especially for immunocompromised individuals. 3️⃣ Emerging Superbugs: Pathogens like Candida auris and Aspergillus fumigatus are developing resistance to multiple treatments, complicating care. 4️⃣ Global Impact: Overuse of antifungals in healthcare and agriculture fuels resistance, creating a worldwide health crisis. 5️⃣ Healthcare Challenges: Resistant fungi can spread rapidly in hospitals, leading to outbreaks that are difficult to control. The Path Forward: Addressing antifungal resistance requires a One Health approach, recognizing the interconnected health of humans, animals, plants, and the environment. Together, we must: ✔️ Educate stakeholders about AMR and its impact. ✔️ Advocate for responsible antimicrobial use. ✔️ Act by implementing better diagnostics, improving infection control, and fostering innovation in antifungal research. By working together, we can combat AMR and protect global health. Let’s commit to informed stewardship today for a healthier tomorrow. https://hubs.ly/Q02Yy_lX0 #WorldAMRWeek #OneHealth #AntifungalResistance #DiagnosticsMatter #ThinkFungus #TestFungus

Welcome, John Bannister, IMMY’s New Director of International Sales & Marketing! With over 20 years of experience in the IVD and diagnostics sectors, John brings a wealth of knowledge in strategy, business development, and international market growth. His expertise includes: ✅ Leading high-impact teams and building strong global partnerships ✅ Securing major supply agreements across diverse regions ✅ Deep insights into infectious diseases, AHD management, and global health initiatives John’s proven ability to drive growth, foster lasting customer and stakeholder relationships, and deliver impactful results aligns seamlessly with IMMY’s mission: improving health and saving lives through world-class fungal diagnostics. As we continue to expand our reach and deliver innovative solutions, John will play a key role in ensuring our global efforts meet the needs of healthcare professionals and patients worldwide. Please join us in welcoming John to the IMMY team! He looks forward to connecting with you and collaborating on strategies to advance our shared goals. 📧 Reach out to John at john-bannister@immy.com #WelcomeToIMMY #Leadership #GlobalHealth #FungalDiagnostics #DiagnosticsInnovation

Next week, IMMY is excited to exhibit at InFocus Latin America, running from November 20-23! Explore our range of rapid and accurate fungal diagnostics, including lateral flow, enzyme immunoassays, and PCR solutions—tools designed to improve health and save lives by transforming laboratory workflows. Be sure to attend our sponsored symposium on November 22: From Confusion to Clarity: Transforming Fungal Diagnostics through Innovative Molecular and Biomarker Testing. Plus, stop by our booth to meet IMMY representatives Diego Caceres Contreras and JT Harrison who will be available to discuss how our solutions can support your diagnostic needs. #InFocus2024 #FungalDiagnostics #ThinkFungus #TestFungus

Fungal Education Friday: The Threat of Candida auris In just over a decade, Candida auris (C. auris) has emerged as a global health threat, reported in 30+ countries and known for its ability to cause outbreaks in healthcare settings. Why C. auris is a Concern: 1️⃣ Resistant to multiple antifungal drugs like Fluconazole. 2️⃣ Difficult to identify with standard lab methods. 3️⃣ Rapidly spreads in hospitals, causing infections with 30-60% mortality rates. Bloodstream infections are particularly severe, especially in critically ill and immunocompromised patients. Early detection is critical for managing outbreaks and protecting vulnerable patients. IMMY’s AurisID® PCR Kit Designed for species-specific detection of C. auris, the AurisID® PCR kit provides results in just 45 minutes—a game-changer compared to the 24-48 hours needed with traditional methods. With 96.6% sensitivity and 100% specificity, it’s a faster, more reliable tool for surveillance and screening, supporting infection control efforts and preventing hospital outbreaks. Together, we can tackle the growing threat of C. auris with innovative diagnostics. Learn more here: https://lnkd.in/gFbDeKSf #FungalEducationFridays #CandidaAuris #CAuris #FungalDiagnostics #HealthcareInnovation #InfectionPrevention #ThinkFungus #TestFungus

Lab managers, are you ready to elevate your diagnostic capabilities? IMMY's rapid fungal diagnostics offer a game-changing solution. Here's a quick list of why you should consider them for your lab. 1. Speed: Results in hours, not days. - Faster diagnosis means quicker treatment. - Reduces patient anxiety and wait times. 2. Accuracy: High precision in results. - Minimizes false positives and negatives. - Enhances trust in lab results. 3. Efficiency: Streamlined workflow. - Increases lab throughput. - Reduces operational bottlenecks. 4. Cost-effectiveness: Saves resources. - Decreases unnecessary tests. - Lowers overall healthcare costs. 5. User-friendly: Easy to implement. - Requires minimal training. - Integrates with existing systems. The big takeaway? IMMY's solutions can redefine your lab's efficiency and patient care. Believe in the power of innovation to drive change. What feature of IMMY's diagnostics would benefit your lab the most? Let us know! https://hubs.ly/Q02Yhsxx0